All the content is editorially independent, no post is sponsored and no paid advertising is accepted. We do not accept unsolicited guest posts.
The blog has developed a focus on oncology & hematology but also covers scientific research of interest in e.g. anesthesiology, respiratory medicine, ophthalmology, osteoporosis and Alzheimer’s disease.
Some themes may end up crossing boundaries e.g. the ubiquitous role inflammation plays in many diseases. The blog also reports on conferences, biotech regions and strategic issues facing the biotechnology, pharmaceutical and medical device industries.
Editor & Lead Writer
The Biotech Strategy Blog editor is Pieter Droppert (@3NT).
Pieter is a blogger, freelance science writer, lawyer and management consultant with over 20 years of pharmaceutical industry experience in the UK, US & Canada.
He has project managed multi-national phase II, III IND drug development trials with leading contract research organizations including Quintiles, conducted medical device clinical research and previously worked as a strategy consultant for a top-tier firm.
Amongst his many qualifications, Pieter is a graduate of the Sloan Fellows program at London Business School where he specialized in strategy and marketing. He has a master of science degree in human and applied physiology from Kings College London and a JD from Rutgers.
As a marketing strategy consultant, Pieter helps pharma & biotech companies understand the oncology market, and focus on the right target and commercial opportunity for new products.
Pieter is member of the National Association of Science Writers (NASW) and associate member of the Association of Health Care Journalists (AHCJ). He has completed journalism, video and multimedia training courses run by Columbia University Graduate School of Journalism, CUNY J-Camp, Poynter’s News University and the Reynolds Center for Business Journalism.
Pieter’s highlight of 2012 was doing a live video interview on the BBC One O’Clock News about the impact of Storm Sandy in New Jersey.